[go: up one dir, main page]

AR067345A1 - USE OF THROMBOMODULIN FOR THE PREPARATION OF A THROMBOLITIC MEDICINAL PRODUCT - Google Patents

USE OF THROMBOMODULIN FOR THE PREPARATION OF A THROMBOLITIC MEDICINAL PRODUCT

Info

Publication number
AR067345A1
AR067345A1 ARP080102791A ARP080102791A AR067345A1 AR 067345 A1 AR067345 A1 AR 067345A1 AR P080102791 A ARP080102791 A AR P080102791A AR P080102791 A ARP080102791 A AR P080102791A AR 067345 A1 AR067345 A1 AR 067345A1
Authority
AR
Argentina
Prior art keywords
thrombomodulin
preparation
thrombolitic
medicinal product
patient
Prior art date
Application number
ARP080102791A
Other languages
Spanish (es)
Inventor
Benning Brohmann
Daniel A Lawrence
Karl-Uwe Petersen
Original Assignee
Paion Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40229136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR067345(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP07013480A external-priority patent/EP2014296A1/en
Application filed by Paion Deutschland Gmbh filed Critical Paion Deutschland Gmbh
Publication of AR067345A1 publication Critical patent/AR067345A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/366—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Uso de trombomodulina para la preparacion de un medicamento para estimular la reperfusion de un tejido u organo isquémico en un paciente que la necesita, en particular un paciente apopléjico. Reivindicacion 15: Uso segun cualquiera de las reivindicaciones precedentes, en el cual la trombomodulina tiene una secuencia de aminoácido correspondiente a la secuencia de aminoácido de trombomodulina soluble madura y comprende una o más de las siguientes modificaciones: Eliminacion de aminoácidos 1-3, M388L, R456, H457Q, S474A, y terminando en P490.Use of thrombomodulin for the preparation of a medicament to stimulate the reperfusion of an ischemic tissue or organ in a patient in need, in particular an apoplegic patient. Claim 15: Use according to any of the preceding claims, wherein the thrombomodulin has an amino acid sequence corresponding to the mature soluble thrombomodulin amino acid sequence and comprises one or more of the following modifications: Elimination of amino acids 1-3, M388L, R456, H457Q, S474A, and ending at P490.

ARP080102791A 2007-07-10 2008-06-27 USE OF THROMBOMODULIN FOR THE PREPARATION OF A THROMBOLITIC MEDICINAL PRODUCT AR067345A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07013480A EP2014296A1 (en) 2007-07-10 2007-07-10 Novel strategies for increasing the reperfusion in obstructed blood vessel
EP08009096 2008-05-16
EP08010333 2008-06-06

Publications (1)

Publication Number Publication Date
AR067345A1 true AR067345A1 (en) 2009-10-07

Family

ID=40229136

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102791A AR067345A1 (en) 2007-07-10 2008-06-27 USE OF THROMBOMODULIN FOR THE PREPARATION OF A THROMBOLITIC MEDICINAL PRODUCT

Country Status (5)

Country Link
EP (1) EP2175872A2 (en)
JP (1) JP2010532776A (en)
AR (1) AR067345A1 (en)
CL (1) CL2008001977A1 (en)
WO (1) WO2009007112A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101672108B1 (en) 2011-11-15 2016-11-02 아사히 가세이 파마 가부시키가이샤 Medicament for therapeutic treatment and/or improvement of sepsis
CN113301907A (en) 2018-10-22 2021-08-24 旭化成制药株式会社 Drug for treating and/or improving sepsis associated with blood coagulation disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2220905T3 (en) * 1992-02-05 2004-12-16 Paion Gmbh PROTEASE RESISTANT THROMBOMODULIN ANALOG.
SI0946185T2 (en) * 1996-11-27 2010-08-31 Aventis Pharma Inc PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
US20010041686A1 (en) * 2000-01-06 2001-11-15 Veronique Mary Novel therapeutic application of enoxaparin
US20020111296A1 (en) * 2000-08-31 2002-08-15 Festoff Barry W. Thrombomodulin analogs for use in recovery of spinal cord injury
ES2249586T3 (en) * 2001-05-25 2006-04-01 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. THE LECTIN TYPE DOMAIN OF THROMBOMODULIN AND ITS THERAPEUTIC USE.
EP1404412B1 (en) * 2001-06-13 2012-03-21 The University of Sydney Protein C for wound healing
AU2003227721A1 (en) * 2003-05-02 2004-11-23 Paion Gmbh Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke

Also Published As

Publication number Publication date
WO2009007112A3 (en) 2009-04-16
EP2175872A2 (en) 2010-04-21
WO2009007112A2 (en) 2009-01-15
JP2010532776A (en) 2010-10-14
WO2009007112A4 (en) 2009-06-11
CL2008001977A1 (en) 2009-03-06

Similar Documents

Publication Publication Date Title
CY1124720T1 (en) ORAL CYTIDINE ANALOGUE FORMULATIONS AND METHODS OF USING THEREOF
BRPI0516830A (en) conveniently implantable sustained release drug compositions
WO2008058547A3 (en) Alpha-lactalbumin composition
AR049985A1 (en) COMBINATION TREATMENT FOR NON-HEMATOLOGICAL MALIGNAL DISEASES
BRPI0010612B8 (en) vaccines
CO6331425A2 (en) COMPOSITIONS THAT INCLUDE N- (3,4-DIFLUORO-2- (2-FLUORO-4-IODOFENILAMINO) 6-METOXIFENIL) -1- (2,3-DIHYDROXIPROXIPROPIL) CICLOPROPAN-1-SULFAMIDA
AR082579A2 (en) A PHARMACEUTICAL COMPOSITION SPONTANEALLY AVAILABLE FOR ORAL ADMINISTRATION, USE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CANCER, METHOD FOR INCREASING BIODISPONIBILITY LEVELS OR REDUCING ITS VARIABILITY
UA88464C2 (en) Method of topical methadone administration providing systemic effect
WO2009088838A3 (en) Triarylmethane analogs and their use in treating cancers
MX2018006299A (en) Peptide analogs of alpha-melanocyte stimulating hormone.
RU2009118942A (en) METHOD FOR STIMULATING TISSUE REGENERATION
WO2006029081A3 (en) Nucleoside-lipid conjugates, their method of preparation and uses thereof
WO2015183995A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
CY1115961T1 (en) ORVEPITANT MALEATE ANHYDRATED FORM OF CRYSTAL MALINE
BRPI0418157A (en) allogeneic tumor therapy
WO2023104114A8 (en) Rna formulations and lipids
MY209484A (en) Cpg amphiphiles and uses thereof
BRPI0406858A (en) Controlled release of highly soluble agents
BRPI0507622B8 (en) compound based on hyaluronic acid, process for preparing a compound or a salt thereof, pharmaceutical composition, medicinal product and medical device for human or veterinary use, and use of a compound or a salt thereof
BRPI0416188A (en) flavoring-containing drug formulations with improved pharmaceutical properties
AR067345A1 (en) USE OF THROMBOMODULIN FOR THE PREPARATION OF A THROMBOLITIC MEDICINAL PRODUCT
WO2007059931A8 (en) New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions
AR048318A1 (en) ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA
UA93365C2 (en) Injectable preparations of diclofenic and its pharmaceutically acceptable salts, and processes for the preparation thereof
BR0316029A (en) Combination

Legal Events

Date Code Title Description
FB Suspension of granting procedure